82% of B2B Buyers Will Take Your Meeting. So Why Can't Your Reps Book One?
Most buyers say yes to cold outreach. The problem isn't volume. It's that reps pitch instead of teach, and quit before the first real conversation.
10 articles in this category
Most buyers say yes to cold outreach. The problem isn't volume. It's that reps pitch instead of teach, and quit before the first real conversation.
We pit BANT, SPIN, and Challenger against each other on speed, deal size, and AI compatibility—and share which one wins for most B2B teams.
BANT is a 1950s relic that filters out the best deals. Here's why you should qualify for pain, authority, and urgency instead.
Most B2B prospecting misses because reps pitch instead of teach. Here's a field-based approach using insight-led outreach and proactive follow-up that...
Cold outreach is often dismissed as spam, but research shows proactive prospecting wins. Here's why you should embrace it, and how to do it right.
BANT is a 1950s relic for transactional sales; MEDDIC wins for complex B2B deals. My head-to-head comparison shows when to use each — and why MEDDIC's...
Imagine you're drowning in leads. Most aren't qualified. Use BANT to filter. Here's how to apply it step by step.
In B2B prospecting, buyers don't want more pitches—they want insight. Here's how to turn your prospecting into a teaching moment that wins meetings.
I used to ask about budget first. It cost me a deal that would've paid my rent for a year. Here's how MEDDIC and SPIN actually qualify deals, and why ...
Why classic solution selling fails in modern B2B and how to prospect by teaching insights, not chasing pain.